Buying a Med Spa or Weight Loss Clinic: Due Diligence Guide | MedClinic Partners

Clinic M&A, Valuation & Growth Advisory

Buying a Med Spa or Weight Loss Clinic: Due Diligence Guide

Acquiring a medical aesthetics or weight loss practice requires specialized due diligence. Here is what buyers need to investigate before signing an LOI or closing a deal.

M
MedClinic Partners Editorial TeamB2B Medical Supply & Compounding Experts
4 min read
Buying a Med Spa or Weight Loss Clinic: Due Diligence Guide β€” MedClinic Partners

Buying a Med Spa or Weight Loss Clinic: Due Diligence Guide

Acquiring a medical aesthetics or weight loss practice can be an excellent investment β€” but only if you do the due diligence correctly. The healthcare sector has unique compliance, licensing, and regulatory considerations that general business due diligence does not cover.

Our team has MBA and JD credentials and has been on both sides of healthcare practice transactions. This guide covers what buyers need to investigate before signing an LOI or closing a deal.

Why Healthcare M&A Due Diligence Is Different

Healthcare practice acquisitions involve risks that do not exist in most other business acquisitions:

Regulatory licenses: Medical practices operate under licenses that may not transfer automatically. A change of ownership can trigger re-licensing requirements.

Corporate practice of medicine: Many states prohibit non-physicians from owning or controlling medical practices. The structure of the acquisition must comply with these rules.

Compliance history: Regulatory violations, board actions, and compliance issues can create liability that survives the acquisition.

Payer contracts: Insurance and Medicare/Medicaid contracts may not transfer to a new owner.

Key person risk: The value of a medical practice often depends heavily on specific providers. Losing those providers post-acquisition can destroy value.

Financial Due Diligence

Revenue Analysis

  • Review 3 years of financial statements (audited or reviewed preferred)
  • Analyze revenue by service line (GLP-1 programs, aesthetic treatments, etc.)
  • Identify recurring vs. one-time revenue
  • Review accounts receivable aging
  • Identify any revenue concentration risk (e.g., one large employer account)

EBITDA Normalization

  • Identify owner compensation above market rate (add back)
  • Identify one-time expenses (add back)
  • Identify non-recurring revenue (subtract)
  • Calculate normalized EBITDA

Patient Metrics

  • Active patient count (seen in last 12 months)
  • New patient acquisition rate
  • Patient retention rate
  • Average revenue per patient
  • Patient lifetime value

Cash Flow

  • Review bank statements for 12–24 months
  • Verify revenue matches bank deposits
  • Identify any unusual cash flows

Legal Due Diligence

Corporate Structure

  • Review corporate formation documents
  • Identify all owners and their ownership percentages
  • Review any shareholder or operating agreements
  • Identify any pending or threatened litigation

Licensing

  • Verify all required licenses are current and in good standing
  • Identify any licenses that may not transfer automatically
  • Review any conditions or restrictions on licenses

Contracts

  • Review all material contracts (leases, vendor agreements, employment agreements)
  • Identify contracts that require consent to assignment
  • Review any non-compete agreements with departing providers

Compliance History

  • Review state medical board records for all providers
  • Review DEA records (if applicable)
  • Review any FDA inspection history (if applicable)
  • Review any HIPAA breach history
  • Review any malpractice claims history

Regulatory Due Diligence

Corporate Practice of Medicine

  • Analyze the state's corporate practice of medicine rules
  • Verify the acquisition structure complies with those rules
  • Identify any required restructuring

Medical Director Requirements

  • Verify the medical director relationship is properly structured
  • Assess whether the medical director will remain post-acquisition
  • Identify any required changes to the medical director structure

Prescribing Compliance

  • Review prescribing protocols for GLP-1 and other compounds
  • Verify patient-prescriber relationship documentation
  • Review supply chain documentation

Compounding Supply Chain

  • Verify the practice sources from licensed, compliant compounders
  • Review COA documentation
  • Identify any supply chain compliance issues

Operational Due Diligence

Staff Assessment

  • Identify key staff and their employment terms
  • Assess retention risk for key providers
  • Review compensation structures
  • Identify any employment disputes

Technology and Systems

  • Review EHR and practice management systems
  • Assess data quality and completeness
  • Identify any technology transition requirements

Facility Assessment

  • Review lease terms (remaining term, renewal options, rent)
  • Assess facility condition
  • Identify any required capital expenditures

Patient Records

  • Verify patient records are complete and properly maintained
  • Assess HIPAA compliance
  • Identify any records management issues

Common Deal Killers

Issues that frequently kill deals or require significant price adjustments:

  • Undisclosed board actions or complaints
  • Revenue that cannot be verified against bank records
  • Key providers who will not stay post-acquisition
  • Lease terms that are unfavorable or expiring
  • Compliance issues with compounding supply chain
  • Corporate practice of medicine structure issues
  • Significant malpractice exposure

How MedClinic Partners Supports Acquisitions

Our team's MBA and JD credentials mean we can support the entire acquisition process β€” from initial assessment through due diligence and close. We have direct relationships with practices considering a sale and can source off-market deals.

Contact us about buy-side advisory β†’

This content is for informational purposes only and does not constitute legal or financial advice. Consult with qualified legal and financial advisors regarding any specific transaction.

Explore Topics

#M&A#acquisition#due diligence#med spa#weight loss clinic#buy-side
M

Written by

MedClinic Partners Editorial Team

B2B Medical Supply & Compounding Experts

The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.

503A/503B CompoundingGLP-1 ProtocolsRegulatory ComplianceMedical Practice Operations

Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.

Practice Advisory

Thinking about a practice acquisition or exit strategy?

Our team has deep pharma and healthcare M&A experience. Submit your info and let's talk.